EG17670A - Process for preparing antiinflammatory composition for external use - Google Patents

Process for preparing antiinflammatory composition for external use

Info

Publication number
EG17670A
EG17670A EG421/83A EG42183A EG17670A EG 17670 A EG17670 A EG 17670A EG 421/83 A EG421/83 A EG 421/83A EG 42183 A EG42183 A EG 42183A EG 17670 A EG17670 A EG 17670A
Authority
EG
Egypt
Prior art keywords
external use
antiinflammatory composition
preparing antiinflammatory
preparing
composition
Prior art date
Application number
EG421/83A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14821545&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EG17670(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG17670A publication Critical patent/EG17670A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EG421/83A 1982-07-13 1983-07-09 Process for preparing antiinflammatory composition for external use EG17670A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57121853A JPS5913714A (ja) 1982-07-13 1982-07-13 外用消炎鎮痛剤

Publications (1)

Publication Number Publication Date
EG17670A true EG17670A (en) 1991-03-30

Family

ID=14821545

Family Applications (1)

Application Number Title Priority Date Filing Date
EG421/83A EG17670A (en) 1982-07-13 1983-07-09 Process for preparing antiinflammatory composition for external use

Country Status (27)

Country Link
US (1) US4678666A (xx)
EP (1) EP0101178B2 (xx)
JP (1) JPS5913714A (xx)
KR (1) KR860001801B1 (xx)
AR (1) AR230375A1 (xx)
AU (1) AU543654B2 (xx)
CA (1) CA1206418A (xx)
CS (1) CS241062B2 (xx)
DD (1) DD209972A5 (xx)
DE (1) DE3373270D1 (xx)
DK (1) DK159640C (xx)
EG (1) EG17670A (xx)
ES (1) ES524094A0 (xx)
FI (1) FI78235C (xx)
GR (1) GR78874B (xx)
HK (1) HK85289A (xx)
HU (1) HU187110B (xx)
IE (1) IE54844B1 (xx)
IL (1) IL69207A0 (xx)
IN (1) IN159679B (xx)
NO (1) NO162494C (xx)
NZ (1) NZ204870A (xx)
PH (1) PH18117A (xx)
PL (1) PL147503B1 (xx)
PT (1) PT77016B (xx)
SG (1) SG30489G (xx)
ZA (1) ZA835058B (xx)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6168413A (ja) * 1984-09-10 1986-04-08 Lion Corp 外用ゲル組成物
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4654169A (en) * 1985-02-06 1987-03-31 Givaudan Corporation Phenyl-aliphatic oximes as odorants
JPS61212516A (ja) * 1985-03-18 1986-09-20 Toyobo Co Ltd ピロキシカム軟膏剤
JPH0794394B2 (ja) * 1986-12-24 1995-10-11 前田薬品工業株式会社 消炎鎮痛外用貼付剤
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
US5241925A (en) * 1988-12-27 1993-09-07 Dermamed Apparatus and techniques for administering veterinary medicaments
US5599768A (en) * 1989-09-21 1997-02-04 E. I. Du Pont De Nemours And Company Stabilization of non-aqueous suspensions
US4988500A (en) * 1989-09-29 1991-01-29 The Procter & Gamble Company Oral compositions
US5324521A (en) * 1989-12-18 1994-06-28 Dermamed Systems for transdermal administration of medicaments
ATE95421T1 (de) * 1990-04-26 1993-10-15 Sagitta Arzneimittel Gmbh Piroxicam enthaltende pharmazeutische zusammensetzung zur topischen anwendung.
FR2679135B1 (fr) * 1991-07-18 1995-05-19 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a adhesivite amelioree et leurs procedes de preparation.
US5362758A (en) * 1992-09-18 1994-11-08 Pfizer Inc. Ophthalmic piroxicam solution
HU209518B (en) * 1992-12-23 1994-06-28 Egyt Gyogyszervegyeszeti Gyar Process for production of free of skin damaging effect unguent preparation containing piroxicam
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
ES2074030B1 (es) * 1994-01-31 1996-02-01 S A L V A T Lab Sa Composiciones portadoras, autocalentadoras y aplicables en terapeutica por via topica.
US5905092A (en) * 1994-09-27 1999-05-18 Virotex Corporation Reel/Frame Topical antibiotic composition providing optimal moisture environment for rapid wound healing that reduces skin contraction
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
GB2305603A (en) * 1995-09-26 1997-04-16 Allied Medical Group Topical cooling gels for reducing excess body fat
KR100288190B1 (ko) * 1998-02-09 2001-04-16 김용규 피록시캄 함유 알콜성 하이드로겔 조성물
KR100342945B1 (ko) * 1999-03-09 2002-07-02 민경윤 항진균제의 외용 약제 조성물 및 이의 제조방법
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
KR100406576B1 (ko) * 2001-06-23 2003-11-20 최후균 경피투여용 패취제
US20060067958A1 (en) * 2004-09-24 2006-03-30 Unilab Pharmatech, Ltd. Pharmaceutical topical gel compositions
JP2006188500A (ja) * 2004-12-08 2006-07-20 Toyama Chem Co Ltd ピロキシカムを含有する外用液剤
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
JP7090549B2 (ja) 2016-03-02 2022-06-24 ノヴァン，インコーポレイテッド 炎症のための治療用組成物およびその治療方法
KR20210133821A (ko) 2020-04-29 2021-11-08 신신제약 주식회사 피록시캄을 함유하는 경피 흡수 제제
WO2022251876A1 (en) * 2021-05-28 2022-12-01 Veterinary Pharmacy Corporation Water soluble complex compositions and methods thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3541584A (en) 1968-08-14 1970-11-17 Bendix Corp Control for fog simulator effects
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
JPS52156913A (en) * 1976-06-21 1977-12-27 Toko Yakuhin Kogyo Kk Production of injectionable medicine
JPS5381616A (en) * 1976-12-27 1978-07-19 Kowa Co Production of antiinflammatory and anodyne ointment
JPS5540604A (en) 1978-09-14 1980-03-22 Mitsui Toatsu Chem Inc Improved local topicum
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts

Also Published As

Publication number Publication date
DE3373270D1 (en) 1987-10-08
US4678666A (en) 1987-07-07
FI78235C (fi) 1989-07-10
DK320583A (da) 1984-01-14
DK159640B (da) 1990-11-12
NO162494C (no) 1990-01-10
AU543654B2 (en) 1985-04-26
PL147503B1 (en) 1989-06-30
IL69207A0 (en) 1983-11-30
FI78235B (fi) 1989-03-31
AR230375A1 (es) 1984-04-30
IE831611L (en) 1984-01-13
AU1676783A (en) 1984-01-19
CS241062B2 (en) 1986-03-13
PT77016B (en) 1986-05-05
ZA835058B (en) 1984-03-28
DD209972A5 (de) 1984-05-30
ES8500738A1 (es) 1984-11-01
HU187110B (en) 1985-11-28
PH18117A (en) 1985-03-22
ES524094A0 (es) 1984-11-01
JPS5913714A (ja) 1984-01-24
DK159640C (da) 1991-04-08
IN159679B (xx) 1987-05-30
KR860001801B1 (ko) 1986-10-23
PL242971A1 (en) 1985-05-21
PT77016A (en) 1983-08-01
HK85289A (en) 1989-11-03
FI832536L (fi) 1984-01-14
FI832536A0 (fi) 1983-07-12
EP0101178A3 (en) 1985-05-22
EP0101178B1 (en) 1987-09-02
EP0101178A2 (en) 1984-02-22
NO162494B (no) 1989-10-02
CA1206418A (en) 1986-06-24
CS528283A2 (en) 1985-07-16
GR78874B (xx) 1984-10-02
JPH0338250B2 (xx) 1991-06-10
SG30489G (en) 1989-08-11
IE54844B1 (en) 1990-02-28
NO832529L (no) 1984-01-16
DK320583D0 (da) 1983-07-12
NZ204870A (en) 1986-06-11
KR840005340A (ko) 1984-11-12
EP0101178B2 (en) 1992-08-12

Similar Documents

Publication Publication Date Title
EG17670A (en) Process for preparing antiinflammatory composition for external use
PL243228A1 (en) Process for preparing very pure axetil cephuroxime
PT73524A (en) Process for preparing dental composition
PL243555A1 (en) Process for preparing n-formyl- and n-hydroxymethyl-3-phenoxy-1-azetidinecarboxamides
GB2133799B (en) Process for preparing a rubber-asphalt composition
HU188278B (en) Process for preparing 4-aryl-4-piperidinyl-carbonols
DE3380061D1 (en) Process for preparing dinitrobenzophenones
PT77831A (en) Process for preparing fluoromethylthiooxacephalosporins
PL243255A1 (en) Process for preparing 3-phenoxy-1-azetidinecarboxamides
PT74225A (en) Process for preparing oral composition
PT77867B (en) Process for preparing aralkyltriazole compounds
DE3380846D1 (en) Process for preparing 2-alkylamino- and 2-amino-5-alkylpyridines
DE3378370D1 (en) Process for preparing polycaprolactone
PL244966A1 (en) Process for preparing novel spiro-3-hetero-azolidinodiones
PT76447B (en) Process for preparing n-substituted-tetrahydrothiazines
IL70218A0 (en) Process for preparing oxazolinoazetidinones
GB2130201B (en) Process for preparing 2-hydroxy-2-phenylethylamines
PL244351A1 (en) Process for preparing novel 5-(2-alkoxy-3-substituted-phenyl)-hydantoins
HUT40420A (en) Process for preparing n-phenyl-pyridine-amino-derivatives
CS455083A2 (en) Process for preparing 1-aryl-2-amino-1-ethanoles
ZA833123B (en) Process for preparing cyanohydrincarboxylates
DE3363916D1 (en) Process for preparing thioethers
PT76406B (en) Process for preparing 2-pyridylalkylamines
PL244814A1 (en) Process for preparing 4/5/-acetyl-2-methylimidazole
YU43535B (en) Process for preparing new ureido-penicillins